À titre de membre permanent, vous pourrez accéder au contenu éditorial et de formation continue, utiliser le moteur de recherche, recevoir nos newsletters, participer aux discussions, télécharger des diapositives et plus encore.
Review, in a case-based approach, current best practices and tenets of PAH diagnosis and explore new evidence-based findings of relevance for managing patients with PAH across the clinical spectrum.
Join Drs. Harrington, Turpie, and Singer for a discussion on novel antiplatelet and anticoagulant therapy in acute coronary syndromes and atrial fibrillation.
Dr. Aryeh Shander discusses the clinical and economic consequences of undiagnosed, unrecognized, and untreated anemia and the benefits and ease of point-of-care testing for all patients.
Angina: more than chest discomfort. Could it be ischemic heart disease? Join our panel of experts, Drs. Weintraub, Scirica, Bhatt, and Cohen as they discuss this important topic.
What effect does doubling the dose of clopidogrel have on outcomes in patients undergoing PCI? Dr. Salim Yusuf discusses the results of the CURRENT-OASIS 7 trial and other new data on antithrombotic agents.
An older patient appearing obviously fatigued and "worn out" presents in the office complaining of heaviness in the chest, and shortness of breath especially with any type of exercise. Not your typical angina patient, or is it? How do you go about working up this patient to make the right diagnosis? Drs. Pepine and Wenger discuss the approach to patients with ischemia and treatment considerations.
This program discusses the optimal use of combination antiplatelet therapy in non-ST elevation ACS, both in the acute and long-term setting. Additionally, the program will touch upon the early use of combination antiplatelet therapy in the setting of STEMI. Referencing the recent joint statement on DES by the Canadian Association of Interventional Cardiologists and the Canadian Cardiovascular Society, the program will also discuss optimal duration of dual antiplatelet therapy, strategies to prevent early discontinuation, and potential management strategies for patients who may require surgery while on dual antiplatelet therapy.
What is the ideal antithrombotic therapy for the management of STEMI patients? Please join Dr Antman and an expert panel as they discuss the latest clinical trial data from the AHA 2006 Scientific Sessions regarding the management of STEMI patients.
What effect does doubling the dose of clopidogrel have on outcomes in patients undergoing PCI? Dr. Salim Yusuf discusses the results of the CURRENT-OASIS 7 trial and other new data on antithrombotic agents.
Angina: more than chest discomfort. Could it be ischemic heart disease? Join our panel of experts, Drs. Weintraub, Scirica, Bhatt, and Cohen as they discuss this important topic.
Review, in a case-based approach, current best practices and tenets of PAH diagnosis and explore new evidence-based findings of relevance for managing patients with PAH across the clinical spectrum.
Join Drs. Harrington, Turpie, and Singer for a discussion on novel antiplatelet and anticoagulant therapy in acute coronary syndromes and atrial fibrillation.